Essity AB (BSN medical)
Essity AB is a global health and hygiene company, with its BSN medical subsidiary being a foundational and leading player in the compression therapy market, best known for the market-leading JOBST brand. Tracing its heritage in compression back to the 1950s, Essity provides a comprehensive portfolio of advanced compression bandages and garments engineered for superior comfort, durability, and clinical efficacy. The company’s solutions are vital for the management of chronic conditions such as lymphedema, lipedema, chronic venous insufficiency (CVI), deep vein thrombosis (DVT), and venous leg ulcers. BSN medical continually drives innovation by integrating advanced technologies like the SoftFit feature for improved comfort, sensitive top bands for moisture control, and 3D-knitted seamless garments such as the JOBST Elvarex Plus. This focus on combining clinical performance with patient-centric design, exemplified by products like the stylish JOBST UltraSheer, solidifies Essity’s position as a preferred global partner for healthcare providers and patients requiring effective and reliable compression therapy.
Latest Market Research Report on Compression Therapy Download PDF Brochure Now
3M Company
3M Company is a diversified global technology and science company that is a major leader in the medical products sector, including compression therapy. Leveraging its legacy of innovation and robust material science, 3M provides a range of clinically validated compression products, including cohesive bandages, compression wraps, and multi-layer systems. The company is particularly renowned for its **Coban 2 Layer Compression System**, which is a staple in clinical practice for the effective management of venous leg ulcers and lymphedema. 3M’s approach focuses on integrating science-driven textile enhancements for superior pressure control, and the products are designed to be patient-friendly and easy to apply in both hospital and home care settings. With a strong global presence, 3M continuously invests in product innovation, such as the new line of compression socks and stockings under the Futuro brand, and engages in strategic collaborations to enhance wound care and support vascular health, thereby maintaining its competitive advantage in the compression therapy market.
Cardinal Health, Inc.
Cardinal Health, Inc. is a prominent global healthcare services and products company that maintains a vital presence in the compression therapy market, primarily through its VTE (Venous Thromboembolism) prevention solutions. The company leverages its expansive global supply chain and tailored product offerings to deliver high-volume, reliable compression devices, particularly for hospital and post-operative care. Cardinal Health’s core offerings in this space center on intermittent pneumatic compression (IPC) devices, which are essential for preventing DVT in immobile and surgical patients. Key products include the **Kendall SCD SmartFlow™ Compression System**, an advanced IPC device featuring patented Vascular Refill Detection Technology (VRD) for customized pressure and enhanced blood circulation. The company’s portfolio also encompasses the **A-V Impulse™ Foot Compression System** and **T.E.D.™ Anti-Embolism Stockings**. By focusing on clinically proven, intuitively designed, and easy-to-use devices, Cardinal Health reinforces its role as a critical provider of VTE prevention and compression solutions across the continuum of patient care.
Medi GmbH & Co. KG
Medi GmbH & Co. KG is a leading German manufacturer of medical aids and technologies that is a key global player in the compression therapy market. The company is highly specialized in creating high-performance knit compression products, offering a wide array of medical compression stockings, orthopedic supports, and wound care solutions. Medi’s core brands, **Mediven** and **Circaid**, are focused on the clinical management of venous and lymphatic disorders such as lymphedema and chronic venous insufficiency. The company excels in advanced manufacturing, utilizing both circular and flat knit designs to provide anatomically correct and custom-fit solutions that prioritize both medical effectiveness and patient comfort through features like antimicrobial finishes. Medi’s strategic commitment to expanding its product range was recently demonstrated by its acquisition of Lympha Press International in 2023, which significantly enhanced its offering in the dynamic pneumatic compression sector. Through its strong global presence and dedication to evidence-based product development, Medi remains at the forefront of the compression therapy industry.
Sigvaris International Group SA (SIGVARIS Group)
SIGVARIS Group is a long-standing, global leader in the production of medical compression hosiery, headquartered in Switzerland. The company’s reputation is built on its textile expertise and the provision of high-quality, customizable compression stockings and garments designed to manage vascular conditions such as chronic venous insufficiency, lymphedema, and deep vein thrombosis. SIGVARIS Group is distinguished by its commitment to marrying clinical therapeutic efficacy with aesthetics and patient comfort, offering products that are effective yet discreet for everyday wear. The company is actively involved in research partnerships and rigorous product testing, ensuring its solutions are evidence-based and meet the highest clinical standards. By providing a comprehensive range of static compression solutions and continuously developing innovative material blends and patient-centric designs, SIGVARIS Group has firmly established itself as a trusted global brand for practitioners and consumers seeking reliable and comfortable compression therapy.
Tactile Medical (Tactile Systems Technology, Inc.)
Tactile Medical is an innovative medical technology company specializing in the pneumatic compression therapy segment, with a primary focus on treating chronic diseases in the home setting, particularly lymphedema and chronic venous disease. The company develops and markets sophisticated home therapy devices, such as the **Flexitouch Plus** and **Entre** systems, which provide advanced, at-home dynamic compression therapy. Tactile Medical’s proprietary technology is engineered to mimic the movements of manual lymph drainage, which helps to reduce chronic swelling, decrease pain, and improve the quality of life for tens of thousands of patients. As a leader in the pneumatic compression market, the company operates a direct national network to support patients with product specialists, trainers, and reimbursement experts. By continually demonstrating clinical efficacy through positive trial results and focusing on advancing the standard of care in the home, Tactile Medical is a driving force in the dynamic compression therapy sector.
Bio Compression Systems, Inc.
Bio Compression Systems, Inc. is a well-established American medical device manufacturer that has been specializing in dynamic and pneumatic compression therapy products since 1983. The company is recognized for its wide array of pumps and garments designed for the effective treatment of various lymphatic and circulatory disorders, including lymphedema, chronic venous insufficiency, and post-operative swelling. Their product portfolio includes venous pumps, arterial pumps, DVT pumps, and cold compression pumps. A key technical differentiator is their use of a quiet, non-peristaltic action in their pumps, which is scientifically proven to closely mimic the body’s natural function to reduce swelling and improve range of motion. Designed for both hospital and convenient home use, their devices prioritize patient comfort and ease of use. Bio Compression Systems remains committed to advancing personalized patient care through continuous product innovation, reinforcing its important role as a provider of effective pneumatic compression solutions.
Smith & Nephew plc
Smith & Nephew plc is a global medical technology company with a broad portfolio that includes advanced wound management solutions, where compression therapy is a critical component. Leveraging its expertise in wound healing, the company offers a comprehensive range of compression wraps and bandages that are often integrated into treatment pathways for chronic wounds, particularly venous leg ulcers. Smith & Nephew is renowned for its dedication to research-led innovation, including the development of advanced systems that may incorporate features like programmable pressure. Notably, their **PICO System**, a single-use negative pressure wound therapy (NPWT) device, often works in conjunction with compression to enhance recovery. By focusing on therapeutic outcomes and integrating its compression offerings with its broader wound care and surgical recovery solutions, Smith & Nephew strengthens its position as a key global player that supports clinicians in delivering effective post-operative and therapeutic care.
DJO Global, Inc. (Enovis Corporation)
DJO Global, Inc., a subsidiary of Enovis Corporation, is a prominent global provider of high-quality orthopedic and recovery solutions, playing a significant role in the compression therapy market. The company is recognized for its focus on digital health integration, offering both pneumatic devices and smart compression garments with connected monitoring capabilities. DJO Global’s compression solutions are integral to its rehabilitation and post-operative care portfolio, primarily aiding in the prevention of deep vein thrombosis (DVT) and managing post-surgical swelling. Their multi-material engineering and emphasis on user experience drive the adoption of their dynamic compression devices among clinicians and patients seeking advanced, connected recovery tools. By actively developing products that address the full spectrum of care—from performance and mobility to post-operative rehabilitation—DJO Global maintains a leading edge in the global market for orthopedic and compression technology.
Medtronic PLC
Medtronic PLC is a global giant in medical technology, delivering a vast range of solutions for various medical conditions, including a dedicated focus on compression therapy, primarily for the prevention of Deep Vein Thrombosis (DVT). Operating as one of the world’s largest medical device companies, Medtronic leverages its extensive reach and technological capabilities to provide advanced post-surgical and therapeutic compression systems globally. Their DVT prevention products are essential components in critical care units and are widely used for immobile and post-operative patients worldwide. Medtronic’s strategy involves continuous investment in research and development to ensure their compression devices are on the cutting edge of clinical safety and effectiveness. By making their advanced, reliable compression solutions an integral part of its comprehensive portfolio, Medtronic maintains a critical role in enhancing patient recovery and preventing life-threatening circulatory complications in healthcare settings globally.
Latest Market Research Report on Compression Therapy Download PDF Brochure Now